Clinical decisions should be individualized based on patient preferences, comorbidities, medication regimens, and treatment goals, with ongoing medical supervision to monitor safety and efficacy
But here's what's being overlooked: GLP-1 activation reduces inflammation in arterial walls, slows atherosclerotic progression, and improves cardiac function independently of weight loss itself
Lets break down the mechanisms at play and explain how you can take charge of managing semaglutide side effects
Much of the current evidence is preclinical (cell and animal studies), and human data is still limited
It should apply the habit in a medically directed, individualized manner based on personal features like body weight, the color of the skin, the intended purposes of the treatment, and general health conditions
Niu, M.-J., Yang, J.-K., Lin, S.-S., Ji, X.-J